Haurwitz Rachel E.

Haurwitz Rachel E. is listed in filings as President and CEO at Caribou Biosciences, Inc.. This profile follows SEC Form 4 activity through Feb 20, 2026, including purchase activity. Recent filings connect the profile to Caribou Biosciences, Inc. (CRBU) and Seer, Inc. (SEER). The current snapshot covers public activity from Jun 14, 2024 to Feb 20, 2026. Reported amounts are shown as $1.2M to $871.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.